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Investigations about the cardioprotective effect of pyruvate in isolated hemoperfused 
pig-hearts under ischemic conditions 
 
In isolated pig-heart it is possible to induce acute myocardial ischemia under well-controlled 
experimental conditions to study their functional and biochemical consequences. The pig-
heart is similar to the human heart with respect to anatomy, size and physiology. Because of 
these similarities, the model has a special suitability in the experimental cardiovascular 
research. 
 
The aim of the present study was to demonstrate the cardioprotective effect of the glycolytic 
intermediate product pyruvate during normothermic perfusion and under ischemic conditions. 
The cessation of bloodflow was produced by occlusion of a coronary artery branch. 
Measurements were made of global (LVP) and regional (IMP, myocardial wall thickness) 
functional parameters. Additional there were made measurements of coronary perfusion-
pressure (CPP), heartrate (HR), coronary bloodflow and regional heartwork (pressure-length-
loops). 
 
The application of supraphysiological concentrations of pyruvate under non ischemic 
conditions of the isolated heart, presented no significant influence of pyruvate on global and 
regional functional parameters. 
Because of short time (15 min) interruption of bloodflow by occlusion of the Ramus 
interventricularis paraconalis (RIVA) an ischemia was induced. Standard values derived 
under a first occlusion was essentiell for the assessment of changes that occurred in 
consequence of a second occlusion. Before a second period of ischemia there was 
supraphysiological concentrations of pyruvate (5 mMol/l) applicated. These conditions 
showed a significant smaller increase of global function (LVP). The measurements of 
regional myocardial function demonstrate, under influence of pyruvate, significant 
improvements of intramyocardial pressure (IMP) and myocardial wall thickness (Wth) in the 
ischemic region. 
 
These results indicate that pyruvates positive inotropic effect is especially striking in hearts 




agents, there is no chronotropic effect in the hearts. The demonstration of pyruvates 
cardioprotective effect in the present study exerts a potential value in the treatment of 
ischemic injured myocardium. 
 
These experiments were made possible by a BMBF-project “Physiologic Hemoperfused 
Organs and Their Applicabilitiy to Replace Animal Experiments” at the Charité Hospital 
Berlin.  
The results of the isolated pig-heart are mostly comparable to conditions of in-vivo-
experiments. In a recent publication, after these experiments were finished, about the 
application of pyruvate in treating heart failure in humans, there could obtained an 
improvement in cardial contractility. Therefore, it has been shown that the isolated pig-heart 
model is suitable to replace experiments of animals. Especially the employment of hearts 
from slaughterhouse animals, it could reduce laboratory animals in experimental studies. 
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